1[1]Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. [J]. Science, 1994, 264 : 382
2[2]Spratt BG. Resistance to antibiotics mediated by target alterations. [J]. Science, 1994,264 : 388
3[3]Cundlife E. Recognition sites for antibiotics within rRNA. In: Hill WE, Dahlberg A, Carret RA, et al. eds. The ribosome: structure, function and evolution. [M]. Washington DC : American Society for Microbiology, 1990: 479
4[4]Baltz RH. Mutagenesis in Streptomyces spp. In : Demain A, Solomon NA,eds. Manual of industrial microbiology and biotechnology. [M]. Washington DC:American Society for Microbiology, 1986 : 184
5[5]Chater KF. The improving prospects for yield increase by genetic engineering in antibiotic-producing streptomycetes. [J]. Bio/Technology, 1990,8: 115
6[6]Shima J, Hesketh A, Okamoto S, et al. Induction of actinorhodin production by rpsL (encoding ribosomal protein S12) mutations that confer streptomycin resistance in Streptornyces lividans and Streptomyces coelicolor A3(2). [J]. J Bacteriol, 1996,178 (24) : 7276
7[7]Hosoya Y,Okamoto S,Muramatsu H,et al. Acquisition of certain streptomycin-resistant (str) mutations enhances antibiotic production in bacteria. [J]. Antimicrob Agents Chemother, 1998,42 (8) : 2041
8[8]Hu H, Ochi K. Novel approach for improving the productivity of antibiotic-producing strains by inducing combined resistant mutations. [J]. Appl Environ Microbiol,2001, 67(4) : 1885
